A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory ...
News Medical on MSN17h
Study uncovers diversity of cancer-associated fibroblasts in skin cancerA study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...
A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...
New research provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Award recognizes Lisata’s data-driven approach and innovative therapies designed to address the unmet medical needs of ...
T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...
THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in ...
Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...
The Centenary Institute has received important funding from the RT Hall Trust to bolster two ground-breaking cancer research initiatives. Almost one ...
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback